Ardent Capital Management, Inc. Bristol Myers Squibb CO Transaction History
Ardent Capital Management, Inc.
- $219 Million
- Q3 2024
A detailed history of Ardent Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ardent Capital Management, Inc. holds 25,983 shares of BMY stock, worth $1.5 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
25,983
Previous 25,983
-0.0%
Holding current value
$1.5 Million
Previous $1.08 Million
24.56%
% of portfolio
0.61%
Previous 0.53%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.16 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.37 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...